Kidney Dosimetry in ¹⁷⁷Lu and ⁹⁰Y Peptide Receptor Radionuclide Therapy: Influence of Image Timing, Time-Activity Integration Method, and Risk Factors

Figure 5

(a) pt no. 35 ¹⁷⁷Lu DOTATATE: MNfix and BI obtained with all experimental points (red and violet lines, resp.) and MN and BI skipping the 3 d point (green and blue lines, resp.); (b) pt no. 45 ¹⁷⁷Lu DOTATOC: MN and BI obtained with all experimental points (red and violet lines, resp.) and BI skipping the 6 h point (blue line).

(a)

(b)